APA (7th ed.) Citation

WJJ, F., JE, C., JS, E., & KS, J. (2019). Anti-PD1 'SHR-1210' aberrantly targets pro-angiogenic receptors and this polyspecificity can be ablated by paratope refinement. MAbs, 11(1), 26. https://doi.org/10.1080/19420862.2018.1550321

Chicago Style (17th ed.) Citation

WJJ, Finlay, Coleman JE, Edwards JS, and Johnson KS. "Anti-PD1 'SHR-1210' Aberrantly Targets Pro-angiogenic Receptors and This Polyspecificity Can Be Ablated by Paratope Refinement." MAbs 11, no. 1 (2019): 26. https://doi.org/10.1080/19420862.2018.1550321.

MLA (9th ed.) Citation

WJJ, Finlay, et al. "Anti-PD1 'SHR-1210' Aberrantly Targets Pro-angiogenic Receptors and This Polyspecificity Can Be Ablated by Paratope Refinement." MAbs, vol. 11, no. 1, 2019, p. 26, https://doi.org/10.1080/19420862.2018.1550321.